Global Flu Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to APO Research, The global Flu Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report presents an overview of global market for Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc.
Flu Vaccine segment by Company
1. To analyze and research the global Flu Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Flu Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Flu Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Flu Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Flu Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flu Vaccine industry.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Flu Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
According to APO Research, The global Flu Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report presents an overview of global market for Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc.
Flu Vaccine segment by Company
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Flu Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Flu Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Flu Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Flu Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Flu Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flu Vaccine industry.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Flu Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Flu Vaccine Sales Value (2019-2030)
1.2.2 Global Flu Vaccine Sales Volume (2019-2030)
1.2.3 Global Flu Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 FLU VACCINE MARKET DYNAMICS
2.1 Flu Vaccine Industry Trends
2.2 Flu Vaccine Industry Drivers
2.3 Flu Vaccine Industry Opportunities and Challenges
2.4 Flu Vaccine Industry Restraints
3 FLU VACCINE MARKET BY COMPANY
3.1 Global Flu Vaccine Company Revenue Ranking in 2023
3.2 Global Flu Vaccine Revenue by Company (2019-2024)
3.3 Global Flu Vaccine Sales Volume by Company (2019-2024)
3.4 Global Flu Vaccine Average Price by Company (2019-2024)
3.5 Global Flu Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Flu Vaccine Company Manufacturing Base & Headquarters
3.7 Global Flu Vaccine Company, Product Type & Application
3.8 Global Flu Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Flu Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Flu Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 FLU VACCINE MARKET BY TYPE
4.1 Flu Vaccine Type Introduction
4.1.1 Trivalent Influenza Vaccine
4.1.2 Quadrivalent Influenza Vaccine
4.2 Global Flu Vaccine Sales Volume by Type
4.2.1 Global Flu Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Flu Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Flu Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Flu Vaccine Sales Value by Type
4.3.1 Global Flu Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Flu Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Flu Vaccine Sales Value Share by Type (2019-2030)
5 FLU VACCINE MARKET BY APPLICATION
5.1 Flu Vaccine Application Introduction
5.1.1 For Children (6 months to 3 years)
5.1.2 For Adults and Children over 3 years
5.2 Global Flu Vaccine Sales Volume by Application
5.2.1 Global Flu Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Flu Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Flu Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Flu Vaccine Sales Value by Application
5.3.1 Global Flu Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Flu Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Flu Vaccine Sales Value Share by Application (2019-2030)
6 FLU VACCINE MARKET BY REGION
6.1 Global Flu Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Flu Vaccine Sales by Region (2019-2030)
6.2.1 Global Flu Vaccine Sales by Region: 2019-2024
6.2.2 Global Flu Vaccine Sales by Region (2025-2030)
6.3 Global Flu Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Flu Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Flu Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Flu Vaccine Sales Value by Region (2025-2030)
6.5 Global Flu Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Flu Vaccine Sales Value (2019-2030)
6.6.2 North America Flu Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Flu Vaccine Sales Value (2019-2030)
6.7.2 Europe Flu Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Flu Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Flu Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Flu Vaccine Sales Value (2019-2030)
6.9.2 Latin America Flu Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Flu Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Flu Vaccine Sales Value Share by Country, 2023 VS 2030
7 FLU VACCINE MARKET BY COUNTRY
7.1 Global Flu Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Flu Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Flu Vaccine Sales by Country (2019-2030)
7.3.1 Global Flu Vaccine Sales by Country (2019-2024)
7.3.2 Global Flu Vaccine Sales by Country (2025-2030)
7.4 Global Flu Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Flu Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Flu Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 CSL
8.2.1 CSL Comapny Information
8.2.2 CSL Business Overview
8.2.3 CSL Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 CSL Flu Vaccine Product Portfolio
8.2.5 CSL Recent Developments
8.3 GSK
8.3.1 GSK Comapny Information
8.3.2 GSK Business Overview
8.3.3 GSK Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 GSK Flu Vaccine Product Portfolio
8.3.5 GSK Recent Developments
8.4 Mylan
8.4.1 Mylan Comapny Information
8.4.2 Mylan Business Overview
8.4.3 Mylan Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Mylan Flu Vaccine Product Portfolio
8.4.5 Mylan Recent Developments
8.5 Hulan Bio
8.5.1 Hulan Bio Comapny Information
8.5.2 Hulan Bio Business Overview
8.5.3 Hulan Bio Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Hulan Bio Flu Vaccine Product Portfolio
8.5.5 Hulan Bio Recent Developments
8.6 AstraZeneca
8.6.1 AstraZeneca Comapny Information
8.6.2 AstraZeneca Business Overview
8.6.3 AstraZeneca Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 AstraZeneca Flu Vaccine Product Portfolio
8.6.5 AstraZeneca Recent Developments
8.7 CCBIO
8.7.1 CCBIO Comapny Information
8.7.2 CCBIO Business Overview
8.7.3 CCBIO Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 CCBIO Flu Vaccine Product Portfolio
8.7.5 CCBIO Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Flu Vaccine Value Chain Analysis
9.1.1 Flu Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Flu Vaccine Sales Mode & Process
9.2 Flu Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Flu Vaccine Distributors
9.2.3 Flu Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Flu Vaccine Sales Value (2019-2030)
1.2.2 Global Flu Vaccine Sales Volume (2019-2030)
1.2.3 Global Flu Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 FLU VACCINE MARKET DYNAMICS
2.1 Flu Vaccine Industry Trends
2.2 Flu Vaccine Industry Drivers
2.3 Flu Vaccine Industry Opportunities and Challenges
2.4 Flu Vaccine Industry Restraints
3 FLU VACCINE MARKET BY COMPANY
3.1 Global Flu Vaccine Company Revenue Ranking in 2023
3.2 Global Flu Vaccine Revenue by Company (2019-2024)
3.3 Global Flu Vaccine Sales Volume by Company (2019-2024)
3.4 Global Flu Vaccine Average Price by Company (2019-2024)
3.5 Global Flu Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Flu Vaccine Company Manufacturing Base & Headquarters
3.7 Global Flu Vaccine Company, Product Type & Application
3.8 Global Flu Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Flu Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Flu Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 FLU VACCINE MARKET BY TYPE
4.1 Flu Vaccine Type Introduction
4.1.1 Trivalent Influenza Vaccine
4.1.2 Quadrivalent Influenza Vaccine
4.2 Global Flu Vaccine Sales Volume by Type
4.2.1 Global Flu Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Flu Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Flu Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Flu Vaccine Sales Value by Type
4.3.1 Global Flu Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Flu Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Flu Vaccine Sales Value Share by Type (2019-2030)
5 FLU VACCINE MARKET BY APPLICATION
5.1 Flu Vaccine Application Introduction
5.1.1 For Children (6 months to 3 years)
5.1.2 For Adults and Children over 3 years
5.2 Global Flu Vaccine Sales Volume by Application
5.2.1 Global Flu Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Flu Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Flu Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Flu Vaccine Sales Value by Application
5.3.1 Global Flu Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Flu Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Flu Vaccine Sales Value Share by Application (2019-2030)
6 FLU VACCINE MARKET BY REGION
6.1 Global Flu Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Flu Vaccine Sales by Region (2019-2030)
6.2.1 Global Flu Vaccine Sales by Region: 2019-2024
6.2.2 Global Flu Vaccine Sales by Region (2025-2030)
6.3 Global Flu Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Flu Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Flu Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Flu Vaccine Sales Value by Region (2025-2030)
6.5 Global Flu Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Flu Vaccine Sales Value (2019-2030)
6.6.2 North America Flu Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Flu Vaccine Sales Value (2019-2030)
6.7.2 Europe Flu Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Flu Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Flu Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Flu Vaccine Sales Value (2019-2030)
6.9.2 Latin America Flu Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Flu Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Flu Vaccine Sales Value Share by Country, 2023 VS 2030
7 FLU VACCINE MARKET BY COUNTRY
7.1 Global Flu Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Flu Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Flu Vaccine Sales by Country (2019-2030)
7.3.1 Global Flu Vaccine Sales by Country (2019-2024)
7.3.2 Global Flu Vaccine Sales by Country (2025-2030)
7.4 Global Flu Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Flu Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Flu Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Flu Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Flu Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Flu Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 CSL
8.2.1 CSL Comapny Information
8.2.2 CSL Business Overview
8.2.3 CSL Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 CSL Flu Vaccine Product Portfolio
8.2.5 CSL Recent Developments
8.3 GSK
8.3.1 GSK Comapny Information
8.3.2 GSK Business Overview
8.3.3 GSK Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 GSK Flu Vaccine Product Portfolio
8.3.5 GSK Recent Developments
8.4 Mylan
8.4.1 Mylan Comapny Information
8.4.2 Mylan Business Overview
8.4.3 Mylan Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Mylan Flu Vaccine Product Portfolio
8.4.5 Mylan Recent Developments
8.5 Hulan Bio
8.5.1 Hulan Bio Comapny Information
8.5.2 Hulan Bio Business Overview
8.5.3 Hulan Bio Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Hulan Bio Flu Vaccine Product Portfolio
8.5.5 Hulan Bio Recent Developments
8.6 AstraZeneca
8.6.1 AstraZeneca Comapny Information
8.6.2 AstraZeneca Business Overview
8.6.3 AstraZeneca Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 AstraZeneca Flu Vaccine Product Portfolio
8.6.5 AstraZeneca Recent Developments
8.7 CCBIO
8.7.1 CCBIO Comapny Information
8.7.2 CCBIO Business Overview
8.7.3 CCBIO Flu Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 CCBIO Flu Vaccine Product Portfolio
8.7.5 CCBIO Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Flu Vaccine Value Chain Analysis
9.1.1 Flu Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Flu Vaccine Sales Mode & Process
9.2 Flu Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Flu Vaccine Distributors
9.2.3 Flu Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
